Diphenhydramine for Acute Migraine
Launched by MONTEFIORE MEDICAL CENTER · Apr 5, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute migraine headache
- • Present to our emergency room in the Bronx, NY for treatment of migraine headache
- Exclusion Criteria:
- • Temperature \> 100.3 F
- • Pheochromocytoma
- • Seizure disorder
- • Parkinson's disease
- • Use of monoamine oxidase (MAO) inhibitors
- • Use of anti-rejection transplant medications
- • Use of potassium supplements
- • Use of pramlintide
About Montefiore Medical Center
Montefiore Medical Center is a leading academic medical institution located in the Bronx, New York, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a principal sponsor of clinical studies, Montefiore fosters a collaborative environment that connects researchers, healthcare professionals, and patients to explore cutting-edge therapies and improve health outcomes. With a strong emphasis on patient-centered care, the center integrates its extensive clinical expertise with robust research capabilities to address a wide range of medical conditions, contributing significantly to the advancement of medical science and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Patients applied
Trial Officials
Benjamin W Friedman
Principal Investigator
Montefiore Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials